Stay updated with breaking news from Clone Cells. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
LEIDEN, the Netherlands, November 1, 2022 / B3C newswire / -- ProteoNic BV, a leading provider of premium vector technology and services for efficient production of biologics, today announced the extension of its license agreement with GigaGen, a biotechnology company advancing transformative antibody drug...
LEIDEN, the Netherlands and BERLIN, Germany, July 05, 2022 / B3C newswire / -- ProteoNic BV, a leading provider of premium vector technology and services for efficient production of biologics, and FyoniBio GmbH, a contract development organization for biopharmaceuticals, today announced they have entered into a...
LEIDEN, the Netherlands, June 15, 2022 / B3C newswire / -- ProteoNic BV, a leading provider of premium vector technology and services for efficient production of biologics, today announced licensing of its premium 2G UNic™ technology for boosting therapeutic protein production to GenScript ProBio, a global contract...